![Multi-Lineage BCR-ABL Expression in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Associated With Improved Prognosis but No Specific Molecular Features - Frontiers Multi-Lineage BCR-ABL Expression in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Associated With Improved Prognosis but No Specific Molecular Features - Frontiers](https://www.frontiersin.org/files/MyHome%20Article%20Library/586567/586567_Thumb_400.jpg)
Multi-Lineage BCR-ABL Expression in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Associated With Improved Prognosis but No Specific Molecular Features - Frontiers
OBM Genetics Quality Assurance/Quality Control of Fluorescence in Situ Hybridization Tests in Hematologic Malignancies
![Figure 2 from A Chronic Myelogenous Leukemia (CML) Case with a Cryptic Insertion of the ABL1 Gene of Chromosome 9 into 22 Resulting in a Fusion Signal on the Derivative 22: 46,XY.ish Figure 2 from A Chronic Myelogenous Leukemia (CML) Case with a Cryptic Insertion of the ABL1 Gene of Chromosome 9 into 22 Resulting in a Fusion Signal on the Derivative 22: 46,XY.ish](https://d3i71xaburhd42.cloudfront.net/70ffbc9aca22f2807aa6bf22ce7c1ac9bad87e11/2-Figure2-1.png)
Figure 2 from A Chronic Myelogenous Leukemia (CML) Case with a Cryptic Insertion of the ABL1 Gene of Chromosome 9 into 22 Resulting in a Fusion Signal on the Derivative 22: 46,XY.ish
![Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease | Leukemia Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-022-01668-0/MediaObjects/41375_2022_1668_Fig1_HTML.png)
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease | Leukemia
![Heterogeneous BCR-ABL1 signal patterns identified by fluorescence in situ hybridization are associated with leukemic clonal evolution and poorer prognosis in BCR-ABL1 positive leukemia | BMC Cancer | Full Text Heterogeneous BCR-ABL1 signal patterns identified by fluorescence in situ hybridization are associated with leukemic clonal evolution and poorer prognosis in BCR-ABL1 positive leukemia | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-019-6137-8/MediaObjects/12885_2019_6137_Fig1_HTML.png)
Heterogeneous BCR-ABL1 signal patterns identified by fluorescence in situ hybridization are associated with leukemic clonal evolution and poorer prognosis in BCR-ABL1 positive leukemia | BMC Cancer | Full Text
![Chronic myeloid leukaemia (CML), ''BCR-ABL1''-positive: chronic phase - CELL - Atlas of Haematological Cytology Chronic myeloid leukaemia (CML), ''BCR-ABL1''-positive: chronic phase - CELL - Atlas of Haematological Cytology](https://www.leukemia-cell.org/atlas/res/photogallery/fig-3.jpg)
Chronic myeloid leukaemia (CML), ''BCR-ABL1''-positive: chronic phase - CELL - Atlas of Haematological Cytology
![Frontiers | Genomic Copy Number Variants in CML Patients With the Philadelphia Chromosome (Ph+): An Update Frontiers | Genomic Copy Number Variants in CML Patients With the Philadelphia Chromosome (Ph+): An Update](https://www.frontiersin.org/files/Articles/697009/fgene-12-697009-HTML/image_m/fgene-12-697009-g001.jpg)
Frontiers | Genomic Copy Number Variants in CML Patients With the Philadelphia Chromosome (Ph+): An Update
![Mixed Phenotype Acute Leukemia with Two Immunophenotypically Distinct B and T Blasts Populations, Double Ph+ Chromosome and Complex Karyotype: Report of an Unusual Case - Samah A. Kohla, Ahmad Al Sabbagh, Halima Mixed Phenotype Acute Leukemia with Two Immunophenotypically Distinct B and T Blasts Populations, Double Ph+ Chromosome and Complex Karyotype: Report of an Unusual Case - Samah A. Kohla, Ahmad Al Sabbagh, Halima](https://journals.sagepub.com/cms/10.4137/CMBD.S24631/asset/images/large/10.4137_cmbd.s24631-fig4.jpeg)
Mixed Phenotype Acute Leukemia with Two Immunophenotypically Distinct B and T Blasts Populations, Double Ph+ Chromosome and Complex Karyotype: Report of an Unusual Case - Samah A. Kohla, Ahmad Al Sabbagh, Halima
![Complete cytogenetic response to Nilotinib in a chronic myeloid leukemia case with a rare e13a3(b2a3) BCR-ABL fusion transcript: A case report Complete cytogenetic response to Nilotinib in a chronic myeloid leukemia case with a rare e13a3(b2a3) BCR-ABL fusion transcript: A case report](https://www.spandidos-publications.com/article_images/mmr/13/3/MMR-13-03-2635-g03.jpg)
Complete cytogenetic response to Nilotinib in a chronic myeloid leukemia case with a rare e13a3(b2a3) BCR-ABL fusion transcript: A case report
![Lsi Bcr Abl Dual Color Dual Fusion Translocation Test (Abbott Laboratories) | Bioz | Ratings For Life-Science Research Lsi Bcr Abl Dual Color Dual Fusion Translocation Test (Abbott Laboratories) | Bioz | Ratings For Life-Science Research](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_1570/pmc06021570/pmc06021570__br-53-152-g002.jpg)
Lsi Bcr Abl Dual Color Dual Fusion Translocation Test (Abbott Laboratories) | Bioz | Ratings For Life-Science Research
![Complete cytogenetic response to Nilotinib in a chronic myeloid leukemia case with a rare e13a3(b2a3) BCR-ABL fusion transcript: A case report Complete cytogenetic response to Nilotinib in a chronic myeloid leukemia case with a rare e13a3(b2a3) BCR-ABL fusion transcript: A case report](https://www.spandidos-publications.com/article_images/mmr/13/3/MMR-13-03-2635-g01.jpg)
Complete cytogenetic response to Nilotinib in a chronic myeloid leukemia case with a rare e13a3(b2a3) BCR-ABL fusion transcript: A case report
![Double fusion signal BCR/ABL, detected by FISH on chromosomes 9 and 22 in a child with ALL | Leukemia Double fusion signal BCR/ABL, detected by FISH on chromosomes 9 and 22 in a child with ALL | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.leu.2401815/MediaObjects/41375_2000_Article_BF2401815_Fig2_HTML.jpg)